• Home>
  • Stocks>
  • Dishman Carbogen Amcis Ltd Share Price
Dishman Carbogen Amcis Ltd share price logo

Dishman Carbogen Amcis Ltd Share Price

(DCAL)

Small Cap

Healthcare Sector

₹202.66▲0.43%

as on 04:01PM, 29 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Dishman Carbogen Amcis Ltd Performance

  • Day's Low

    Day's High

    ₹201.58
    Day's Price Range
    ₹206.92

  • 52 Week's Low

    52 Week's High

    ₹133
    52-Week Price Range
    ₹307.98
1 Month Return-8.07 %
3 Month Return-11.5 %
1 Year Return-12.7 %
Previous Close₹203.53
Open₹203.90
Volume2.03L
Upper Circuit₹244.23
Lower Circuit₹162.82
Market Cap₹3,177.37Cr

Dishman Carbogen Amcis Ltd Fundamentals

P/E Ratio

-28.95

PEG Ratio

-10.19

Market Cap

₹3,177.37 Cr

P/B Ratio

0.91

EPS

-9.79

Dividend Yield

0

Sector

Pharmaceuticals

ROE

0

Dishman Carbogen Amcis Ltd Share analysis

Excluding Excise Duty and Other Income, represents Net Revenue

Dishman Carbogen Amcis Ltd revenue growth forecast

Expected growth rate Q1, FY2023:-0.60%

Forecast

Actual

Source: S&P Global Market Intelligence

Key events for Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Secures Drug License, Shares Surge - 11 Apr, 2025

    Dishman Carbogen Amcis Ltd's subsidiary received a drug manufacturing license from NMPA in China, leading to significant share price increases of 5% and 10%. The company aims for revenue growth and improved EBITDA margins in the coming years.

  • Dishman Carbogen Amcis Secures Drug Manufacturing License in China - 09 Apr, 2025

    Dishman Carbogen Amcis Ltd's subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has received a Drug Manufacturing License from China's NMPA, enabling regulatory-compliant manufacturing operations in Shanghai. This milestone enhances the company's international manufacturing capabilities.

  • Dishman Carbogen Amcis Allocates INR 50 Crore in Debentures - 26 Mar, 2025

    Dishman Carbogen Amcis Limited has allotted 5,000 non-convertible debentures worth INR 50 crore to raise capital through private placement, enhancing financial stability.

  • Dishman Carbogen Reports Growth and GMP Compliance - 20 Mar, 2025

    Dishman Carbogen Amcis Ltd's subsidiary received a GMP compliance certificate for its French site. The company reported a 4.8% increase in net sales for December 2024, with a substantial rise in net profit and EBITDA.

  • Dishman Carbogen Amcis Approves ₹50 Crore Debenture Issuance - 13 Mar, 2025

    Dishman Carbogen Amcis Ltd's shares increased by 1.90% following the board's approval for ₹50 crore in non-convertible debentures, enhancing liquidity and capital structure.

Insights on Dishman Carbogen Amcis Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.74% to 9.49% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 59.32% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 63.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 113.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 33.09 Cr → 4.63 Cr (in ₹), with an average decrease of 86.0% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.22% to 1.06% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 795.69 Cr → 690.01 Cr (in ₹), with an average decrease of 13.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 30.51% to 29.93% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DCAL stock has moved down by -7.7%

Dishman Carbogen Amcis Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹651.09Cr (-)₹654.71Cr (↑0.56%)₹523.78Cr (↓20.00%)₹789.04Cr (↑50.64%)₹682.34Cr (↓13.52%)
Net Income-₹59.63Cr (-)-₹69.92Cr (↑17.26%)-₹77.57Cr (↑10.94%)₹33.09Cr (↓142.66%)₹4.63Cr (↓86.01%)
Net Profit Margin-9.16% (-)-10.68% (↑16.59%)-14.81% (↑38.67%)4.19% (↓128.29%)0.68% (↓83.77%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,744.81Cr (-)₹5,214.31Cr (↓9.23%)₹5,360.22Cr (↑2.80%)₹5,286.01Cr (↓1.38%)
Total Liabilities₹1,070.19Cr (-)₹982.53Cr (↓8.19%)₹1,245.91Cr (↑26.81%)₹1,233.43Cr (↓1.00%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹196.70Cr (-)-₹1.51Cr (↓100.77%)₹227.35Cr (↓15,156.29%)-₹52.90Cr (↓123.27%)₹24.17Cr (↓145.69%)

Dishman Carbogen Amcis Ltd Index Inclusions

BSE Healthcare

₹42,211.90

-0.81 (▲-343.75%)

BSE Small-Cap

₹48,238.69

0.09 (▲45.23%)

Dishman Carbogen Amcis Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
59.32%
0.00
Foreign Institutions
9.49%
0.00
Mutual Funds
1.06%
0.00
Retail Investors
29.93%
0.00
Others
0.2%
0.00

Dishman Carbogen Amcis Ltd Key Indicators

Details2020
Return On Equity %0.88
Details20202021202220232024
Return On Assets %2.67-2.870.35-0.56-2.9
Details20202021202220232024
Book Value Per Share (₹)364.25363.45353.89370.51358.9
Details20202021202220232024
Earning Per Share (₹)10.1-10.531.15-1.9-9.79

Dishman Carbogen Amcis Ltd Valuation

Dishman Carbogen Amcis Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-599.35x)

March 22, 2023

Today (-28.95x)

April 29, 2025

Industry (54.77x)

April 29, 2025

Highest (338.29x)

July 25, 2022

LowHigh

Dishman Carbogen Amcis Ltd Earnings and Dividends

  • Dishman Carbogen Amcis Ltd Earnings Results

    Dishman Carbogen Amcis Ltd’s net profit jumped 107.76% since last year same period to ₹4.63Cr in the Q3 2024-2025. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated -86.01% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Dishman Carbogen Amcis Ltd Dividends May,2019

    In the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 - translating a dividend yield of 0.10%.

    Read More about Dividends

Dishman Carbogen Amcis Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Dishman Carbogen Amcis Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Dishman Carbogen Amcis Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Ltd
NA₹3,177.37 Cr28.43%0.58-₹154 Cr₹2,615 Cr
Vaishali Pharma Ltd
Vaishali Pharma Ltd
NA₹147.07 Cr35.43%0.62NANA
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd
NA₹5,411.31 Cr432.02%0.50₹33 Cr₹204 Cr
Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd
NA₹1,510.04 Cr381.87%0.52NANA
RPG Life Sciences Ltd
RPG Life Sciences Ltd
NA₹3,596.41 Cr157.18%0.51NANA
See all

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd is a Gujarat, India based pharmaceutical manufacturing firm, listed on National Stock Exchange and Bombay Stock Exchange. It is the leading supplier of active pharmaceutical ingredients (API) for pharmaceutical and biotechnology companies, and a contract manufacturer for generic APIs, complex intermediates and custom synthesis products. The company is committed to deliver high quality and reliable products, as well as integrated services, including advanced process technology, cGMP manufacturing practices and project management. Dishman Carbogen Amcis has strong research and development capabilities with an in-depth knowledge of chemistry, established IP and access to world class facilities that enables faster delivery of cost effective products to global customers.

Revenue: ₹682.34Cr as on December 2024 (Q4 24)
Net Profit: ₹4.63Cr as on December 2024 (Q4 24)
Listing date: 21 Sep, 2017
Chairperson Name: Janmejay R Vyas
OrganisationDishman Carbogen Amcis Ltd
HeadquartersGujarat
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Dishman Carbogen Amcis Ltd

What is Dishman Carbogen Amcis Ltd price today?

Dishman Carbogen Amcis Ltd share price today stands at ₹202.66, Open: ₹203.9, Previous Close: ₹203.53, High: ₹206.92, Low: ₹201.58, 52 Week High: ₹307.98, 52 Week Low: ₹133.

How to Buy Dishman Carbogen Amcis Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Dishman Carbogen Amcis Ltd shares

What are today's traded volumes of Dishman Carbogen Amcis Ltd?

Today's traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 2.03L.

What is today's market capitalisation of Dishman Carbogen Amcis Ltd?

Today's market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹3177.37Cr.

What is the 52 Week High and Low Range of Dishman Carbogen Amcis Ltd?

Dishman Carbogen Amcis Ltd (DCAL)
Price
52 Week High
₹307.98
52 Week Low
₹133

How much percentage Dishman Carbogen Amcis Ltd is down from its 52 Week High?

Dishman Carbogen Amcis Ltd (DCAL) share price is ₹202.66. It is down -34.20% from its 52 Week High price of ₹307.98

How much percentage Dishman Carbogen Amcis Ltd is up from its 52 Week low?

Dishman Carbogen Amcis Ltd (DCAL) share price is ₹202.66. It is up 52.38% from its 52 Week Low price of ₹133